Anti-ICAM-1/CD54 Antibody (FITC), Mouse Monoclonal sinobiological 10346-MM01-F

$100.00
In stock
SKU
10346-MM01-F
Catalog No.SizePrice (USD)
10346-MM01-F-2525 Tests$103.68
10346-MM01-F-100100 Tests$222.17

General Information

Product nameAnti-ICAM-1/CD54 Antibody (FITC), Mouse Monoclonal
Validated applicationsFCM (FAQ Protocol)
Species reactivityReacts with: Human
SpecificityHuman ICAM-1/CD54
ImmunogenRecombinant Human ICAM-1 protein (Catalog#10346-H08H)
PreparationThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human ICAM-1 / CD54 (rh ICAM-1 / CD54; Catalog#10346-H08H; NP_000192.2; Met 1-Glu 480) and conjugated with FITC under optimum conditions, the unreacted FITC was removed.
SourceMonoclonal Mouse IgG1 Clone #01
PurificationProtein A
FormulationPBS solution containing 0.5% BSA and 0.09% sodium azide
Concentration10 μl/Test, 0.1 mg/ml
ConjugateFITC
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageThis antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.

Synonyms: Anti-BB2 Antibody; Anti-CD54 Antibody; Anti-P3.58 Antibody

Image / Experimental Information

Image 1 DescriptionProfile of anti-ICAM1(CD54) reactivity on Daudi cells analyzed by flow cytometry.
Image 1 Alt TextHuman ICAM-1/CD54 Flow Cytometry (FC) 2576
Image 1 URLSource image
Image 2 DescriptionProfile of anti-ICAM1(CD54) reactivity on Daudi cells analyzed by flow cytometry.
Image 2 Alt TextHuman ICAM-1/CD54 Flow Cytometry (FC) 5148
Image 2 URLSource image

Background Information

Full Nameintercellular adhesion molecule 1
DescriptionIntercellular adhesion molecule-1 (ICAM-1, or CD54) is a 90 kDa member of the immunoglobulin (Ig) superfamily and is critical for the firm arrest and transmigration of leukocytes out of blood vessels and into tissues. ICAM-1 is constitutively present on endothelial cells, but its expression is increased by proinflammatory cytokines. The endothelial expression of ICAM-1 is increased in atherosclerotic and transplant-associated atherosclerotic tissue and animal models of atherosclerosis. Additionally, ICAM-1 has been implicated in the progression of autoimmune diseases. ICAM-1 is a ligand for LFA-1(integrin). When activated, leukocytes bind to endothelial cells via ICAM-1/LFA-1 interaction and then transmigrate into tissues. Presence with heavy glycosylation and other structural characteristics, ICAM-1 possesses binding sites for some immune-associated ligands and serves as the binding site for entry of the major group of human Rhinovirus (HRV) into various cell types. ICAM-1 also becomes known for its affinity for Plasmodium falciparum-infected erythrocytes (PFIE), providing more of a role in infectious disease. Previous studies have shown that ICAM-1 is involved in inflammatory reactions and that a defect in ICAM-1 gene inhibits allergic contact hypersensitivity.
Research Areas
  • Neuroinflammation
References
  1. Xu H, et al. (2001) The role of ICAM-1 molecule in the migration of Langerhans cells in the skin and regional lymph node. Eur J Immunol. 31(10): 3085-93.
  2. Terol MJ, et al. (2003) Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome. Ann Oncol. 14(3): 467-74.
  3. Mendez MP, et al. (2006) Shedding of soluble ICAM-1 into the alveolar space in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol. 290(5): L962-70.
  4. Lawson C, et al. (2009) ICAM-1 signaling in endothelial cells. Pharmacol Rep. 61(1): 22-32.

Reviews

Write Your Own Review
You're reviewing:Anti-ICAM-1/CD54 Antibody (FITC), Mouse Monoclonal sinobiological 10346-MM01-F
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.